AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Stifel Financial Corp

$79.76 -$5.78 (-6.76%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$79.69
Day Range
$78.92$80.22
Year Range
$67.81$89.83
Market Cap
12.09B
AVG Volume
1.27M
Trailing/Forward PE
8.77/10.62
PEG ratio
0.58
Dividend Yield
1.66%
Next Earnings Date
2026-10-28
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q26.68B
26 Q16.51B
25 Q46.3B
25 Q36.12B
25 Q25.96B
25 Q15.94B
24 Q45.89B
24 Q35.69B
24 Q25.48B
24 Q15.26B
Net Income (USD) · TTM
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2953.63M
26 Q1882.21M
25 Q4683.78M
25 Q3663.42M
25 Q2610.56M
25 Q1620.8M
24 Q4731.38M
24 Q3649.86M
24 Q2559.51M
24 Q1528.57M
Operating Income (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q21.64B
26 Q11.35B
25 Q4871.14M
25 Q3829.43M
25 Q2760.04M
25 Q1773.12M
24 Q4928.44M
24 Q3868.24M
24 Q2761.01M
24 Q1715.5M
EBITDA (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q21.73B
26 Q11.48B
25 Q41.02B
25 Q3912.56M
25 Q2843.02M
25 Q1857.98M
24 Q41.01B
24 Q3957.9M
24 Q2848.72M
24 Q1798.96M
Cash Flows (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2417.67M
26 Q1830.69M
25 Q4993.33M
25 Q31.36B
25 Q2957.93M
25 Q1808.23M
24 Q4416.65M
24 Q31.72M
24 Q2304.01M
24 Q1228.48M
EPS (USD) · TTM
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q28.48
26 Q17.77
25 Q45.88
25 Q35.66
25 Q25.16
25 Q15.23
24 Q46.24
24 Q35.53
24 Q24.71
24 Q14.4
Expenses (USD) · TTM
01B2B3B4BSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q22.63B
26 Q13.47B
25 Q43.33B
25 Q33.21B
25 Q23.08B
25 Q13.05B
24 Q42.99B
24 Q32.86B
24 Q22.76B
24 Q12.63B
Shares Outstanding (USD) · TTM
-500M-250M0250M500MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SF Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-107.35M
26 Q1-186.07M
25 Q4-181.26M
25 Q398.66M
25 Q279.95M
25 Q121.96M
24 Q4-9.66M
24 Q389.78M
24 Q2194.52M
24 Q1265.76M
Dividends (USD)
00.20.40.6Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
SF Dividends (USD) by quarter
PeriodDividends (USD)
Sep 260.34
Jun 260.34
Mar 260.34
Dec 250.31
Sep 250.46
Jun 250.46
Mar 250.46
Dec 240.28
Sep 240.28
Jun 240.42
Employee Count
02.5K5K7.5K10K2016201720182019202020212022202320242025
SF Employee Count by quarter
PeriodEmployee Count
20259K
20249K
20239K
20229K
20218.6K
20208.5K
20198.3K
20187.5K
20177.1K
20167.1K
PE Ratio
68101214med 11.64Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SF PE Ratio by quarter
PeriodPE Ratio
Sep 268.6
Sep 268.78
Aug 268.76
Aug 268.73
Aug 269.23
Aug 268.96
Jul 269.66
Jul 269.42
Jul 268.99
Jul 268.76
Jul 268.53
Jun 268.07
Jun 268.57
Jun 268.47
Jun 268.24
May 268.17
May 268.46
May 268.66
May 268.91
May 2611.58
Apr 2611.6
Apr 2612.37
Apr 2611.61
Apr 2611.13
Mar 2610.66
Mar 2610.64
Mar 2610.56
Mar 2611
Feb 2611.13
Feb 2612.43
Feb 2612.33
Feb 2613.53
Jan 2612.78
Jan 2613.29
Jan 2613.44
Jan 2613.49
Jan 2613.3
Dec 2513.33
Dec 2513.2
Dec 2513.46
Dec 2513.08
Nov 2512.64
Nov 2512.12
Nov 2512.52
Nov 2512.62
Oct 2513.36
Oct 2513.31
Oct 2512.44
Oct 2512.08
Oct 2512.57
Sep 2512.94
Sep 2512.98
Sep 2513.01
Sep 2512.7
Aug 2513.01
Aug 2512.9
Aug 2512.89
Aug 2512.6
Aug 2512.51
Jul 2512.68
Jul 2512.37
Jul 2512.17
Jul 2512.29
Jun 2511.66
Jun 2510.96
Jun 2510.73
Jun 2510.86
May 2510.6
May 2510.48
May 2511.12
May 2510.28
May 258.48
Apr 258.14
Apr 258.07
Apr 257.79
Apr 257.51
Mar 258.9
Mar 259.32
Mar 259.05
Mar 259.15
Feb 2510.07
Feb 2511.08
Feb 2511.77
Feb 2512.09
Jan 2512.36
Jan 2512.19
Jan 2512.15
Jan 2511.09
Jan 2511.54
Dec 2411.38
Dec 2411.14
Dec 2411.79
Dec 2412.15
Nov 2412.35
Nov 2412.4
Nov 2412.21
Nov 2412.3
Nov 2412.82
Oct 2412.84
Oct 2412.68
Free Cash Flow Yield
0%5%10%15%20%med 11.15%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 265.09%
Sep 264.99%
Aug 265%
Aug 265.02%
Aug 264.75%
Aug 264.89%
Jul 269.75%
Jul 2610%
Jul 2610.47%
Jul 2610.75%
Jul 2611.05%
Jun 2611.67%
Jun 2610.99%
Jun 2611.12%
Jun 2611.43%
May 2611.52%
May 2611.13%
May 2610.87%
May 2610.56%
May 2612.55%
Apr 2612.52%
Apr 2611.74%
Apr 2612.51%
Apr 2613.05%
Mar 2613.62%
Mar 2613.66%
Mar 2613.76%
Mar 2613.21%
Feb 2613.05%
Feb 2616.54%
Feb 2616.66%
Feb 2615.18%
Jan 2616.08%
Jan 2615.46%
Jan 2615.29%
Jan 2615.23%
Jan 2615.45%
Dec 2515.41%
Dec 2515.56%
Dec 2515.27%
Dec 2515.71%
Nov 2516.25%
Nov 2516.95%
Nov 2516.41%
Nov 2516.29%
Oct 2511.74%
Oct 2511.79%
Oct 2512.62%
Oct 2512.99%
Oct 2512.48%
Sep 2512.13%
Sep 2512.09%
Sep 2512.06%
Sep 2512.35%
Aug 2512.06%
Aug 2512.16%
Aug 2512.18%
Aug 2512.45%
Aug 2510.41%
Jul 2510.27%
Jul 2510.52%
Jul 2510.7%
Jul 2510.6%
Jun 2511.16%
Jun 2511.88%
Jun 2512.13%
Jun 2511.99%
May 2512.28%
May 2512.43%
May 2511.7%
May 2512.66%
May 256.72%
Apr 257%
Apr 257.05%
Apr 257.31%
Apr 257.59%
Mar 256.4%
Mar 256.11%
Mar 256.3%
Mar 256.23%
Feb 255.66%
Feb 250.02%
Feb 250.02%
Feb 250.02%
Jan 250.02%
Jan 250.02%
Jan 250.02%
Jan 250.02%
Jan 250.02%
Dec 240.02%
Dec 240.02%
Dec 240.02%
Dec 240.02%
Nov 240.02%
Nov 240.02%
Nov 240.02%
Nov 240.02%
Nov 244.24%
Oct 244.23%
Oct 244.28%
Price to Sales
0.811.21.41.6med 1.28Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SF Price to Sales by quarter
PeriodPrice to Sales
Sep 261.23
Sep 261.25
Aug 261.25
Aug 261.25
Aug 261.32
Aug 261.28
Jul 261.31
Jul 261.28
Jul 261.22
Jul 261.19
Jul 261.16
Jun 261.09
Jun 261.16
Jun 261.15
Jun 261.12
May 261.11
May 261.15
May 261.17
May 261.21
May 261.26
Apr 261.26
Apr 261.34
Apr 261.26
Apr 261.21
Mar 261.16
Mar 261.16
Mar 261.15
Mar 261.19
Feb 261.21
Feb 261.35
Feb 261.34
Feb 261.47
Jan 261.38
Jan 261.44
Jan 261.46
Jan 261.46
Jan 261.44
Dec 251.44
Dec 251.43
Dec 251.46
Dec 251.42
Nov 251.37
Nov 251.31
Nov 251.36
Nov 251.37
Oct 251.37
Oct 251.36
Oct 251.27
Oct 251.24
Oct 251.29
Sep 251.33
Sep 251.33
Sep 251.33
Sep 251.3
Aug 251.33
Aug 251.32
Aug 251.32
Aug 251.29
Aug 251.31
Jul 251.33
Jul 251.29
Jul 251.27
Jul 251.28
Jun 251.22
Jun 251.15
Jun 251.12
Jun 251.14
May 251.11
May 251.1
May 251.16
May 251.07
May 251.05
Apr 251.01
Apr 251
Apr 250.97
Apr 250.93
Mar 251.11
Mar 251.16
Mar 251.12
Mar 251.14
Feb 251.25
Feb 251.27
Feb 251.35
Feb 251.38
Jan 251.41
Jan 251.39
Jan 251.39
Jan 251.27
Jan 251.32
Dec 241.3
Dec 241.27
Dec 241.35
Dec 241.39
Nov 241.41
Nov 241.42
Nov 241.39
Nov 241.41
Nov 241.31
Oct 241.31
Oct 241.3
EV/EBITDA
24681012med 7.66Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 263.08
Sep 263.18
Aug 263.17
Aug 263.15
Aug 263.43
Aug 263.27
Jul 265.74
Jul 265.6
Jul 265.34
Jul 265.2
Jul 265.06
Jun 264.79
Jun 265.09
Jun 265.03
Jun 264.89
May 264.85
May 265.02
May 265.14
May 265.3
May 267.66
Apr 267.68
Apr 268.2
Apr 267.68
Apr 267.37
Mar 267.05
Mar 267.03
Mar 266.98
Mar 267.27
Feb 267.36
Feb 268.34
Feb 268.27
Feb 269.14
Jan 268.59
Jan 268.97
Jan 269.07
Jan 269.11
Jan 268.97
Dec 259
Dec 258.9
Dec 259.09
Dec 258.82
Nov 258.5
Nov 258.12
Nov 258.4
Nov 258.48
Oct 2510.67
Oct 2510.63
Oct 2510
Oct 259.74
Oct 2510.1
Sep 2510.37
Sep 2510.39
Sep 2510.42
Sep 2510.2
Aug 2510.42
Aug 2510.34
Aug 2510.33
Aug 2510.12
Aug 259.05
Jul 259.17
Jul 258.95
Jul 258.81
Jul 258.89
Jun 258.44
Jun 257.93
Jun 257.76
Jun 257.86
May 257.67
May 257.58
May 258.05
May 257.44
May 255.89
Apr 255.64
Apr 255.6
Apr 255.39
Apr 255.19
Mar 256.2
Mar 256.5
Mar 256.3
Mar 256.37
Feb 257.04
Feb 256.94
Feb 257.4
Feb 257.62
Jan 257.8
Jan 257.69
Jan 257.66
Jan 256.94
Jan 257.24
Dec 247.14
Dec 246.98
Dec 247.42
Dec 247.66
Nov 247.8
Nov 247.83
Nov 247.7
Nov 247.76
Nov 247.37
Oct 247.39
Oct 247.28
Price/Operating Cashflow
050100150med 8.08Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2618.29
Sep 2618.68
Aug 2618.64
Aug 2618.56
Aug 2619.63
Aug 2619.05
Jul 269.22
Jul 268.99
Jul 268.58
Jul 268.36
Jul 268.14
Jun 267.71
Jun 268.18
Jun 268.08
Jun 267.87
May 267.8
May 268.07
May 268.27
May 268.51
May 267.5
Apr 267.52
Apr 268.02
Apr 267.52
Apr 267.21
Mar 266.91
Mar 266.89
Mar 266.84
Mar 267.12
Feb 267.21
Feb 265.77
Feb 265.72
Feb 266.28
Jan 265.93
Jan 266.17
Jan 266.24
Jan 266.26
Jan 266.17
Dec 256.19
Dec 256.13
Dec 256.25
Dec 256.07
Nov 255.87
Nov 255.63
Nov 255.81
Nov 255.86
Oct 258
Oct 257.97
Oct 257.45
Oct 257.23
Oct 257.53
Sep 257.75
Sep 257.77
Sep 257.79
Sep 257.61
Aug 257.79
Aug 257.73
Aug 257.72
Aug 257.54
Aug 258.73
Jul 258.85
Jul 258.64
Jul 258.5
Jul 258.58
Jun 258.15
Jun 257.65
Jun 257.49
Jun 257.58
May 257.4
May 257.32
May 257.77
May 257.18
May 2512.65
Apr 2512.13
Apr 2512.04
Apr 2511.62
Apr 2511.19
Mar 2513.28
Mar 2513.9
Mar 2513.49
Mar 2513.64
Feb 2515.02
Feb 25101.39
Feb 25107.7
Feb 25110.66
Jan 25113.04
Jan 25111.52
Jan 25111.12
Jan 25101.48
Jan 25105.55
Dec 24104.08
Dec 24101.96
Dec 24107.9
Dec 24111.12
Nov 24113
Nov 24113.41
Nov 24111.67
Nov 24112.51
Nov 2419.23
Oct 2419.27
Oct 2419.04
Price to Book
0.811.21.41.6med 1.37Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SF Price to Book by quarter
PeriodPrice to Book
Sep 261.36
Sep 261.39
Aug 261.39
Aug 261.38
Aug 261.46
Aug 261.42
Jul 261.42
Jul 261.39
Jul 261.33
Jul 261.29
Jul 261.26
Jun 261.19
Jun 261.26
Jun 261.25
Jun 261.21
May 261.2
May 261.25
May 261.28
May 261.31
May 261.32
Apr 261.33
Apr 261.42
Apr 261.33
Apr 261.27
Mar 261.22
Mar 261.22
Mar 261.21
Mar 261.26
Feb 261.27
Feb 261.43
Feb 261.42
Feb 261.56
Jan 261.47
Jan 261.53
Jan 261.55
Jan 261.56
Jan 261.53
Dec 251.54
Dec 251.52
Dec 251.55
Dec 251.51
Nov 251.46
Nov 251.4
Nov 251.44
Nov 251.45
Oct 251.46
Oct 251.45
Oct 251.36
Oct 251.32
Oct 251.37
Sep 251.41
Sep 251.42
Sep 251.42
Sep 251.39
Aug 251.42
Aug 251.41
Aug 251.41
Aug 251.37
Aug 251.4
Jul 251.42
Jul 251.39
Jul 251.36
Jul 251.38
Jun 251.31
Jun 251.23
Jun 251.2
Jun 251.22
May 251.19
May 251.17
May 251.25
May 251.15
May 251.09
Apr 251.05
Apr 251.04
Apr 251
Apr 250.97
Mar 251.15
Mar 251.2
Mar 251.16
Mar 251.18
Feb 251.3
Feb 251.3
Feb 251.38
Feb 251.41
Jan 251.44
Jan 251.43
Jan 251.42
Jan 251.3
Jan 251.35
Dec 241.33
Dec 241.3
Dec 241.38
Dec 241.42
Nov 241.44
Nov 241.45
Nov 241.43
Nov 241.44
Nov 241.33
Oct 241.33
Oct 241.31
Stifel Financial Corp
SF
Stockpicker

Video analysis: SF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SF

Amundi Cuts Stock Position in Stifel Financial Corporation $SF

defenseworld.net · 12 Sep 2026

Amundi Cuts Stock Position in Stifel Financial Corporation $SF

Amundi reduced its holdings in shares of Stifel Financial Corporation (NYSE: SF) by 68.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 153,885 shares of the financial services provider's stock after selling 337,532 shares during the period. Amundi

KBW Announces Index Rebalancing for Third-Quarter 2026

globenewswire.com · 11 Sep 2026

KBW Announces Index Rebalancing for Third-Quarter 2026

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Keefe, Bruyette & Woods, Inc., a leading specialist investment bank to the financial services and fintech sectors, and a wholly owned subsidiary of Stifel Financial Corp. (NYSE: SF), announces the upcoming index rebalancing for the third quarter of 2026.

Mission Group gets Stifel 'buy' as recovery outpaces valuation

proactiveinvestors.co.uk · 10 Sep 2026

Mission Group gets Stifel 'buy' as recovery outpaces valuation

MISSION Group (LSE:TMG) drew a bullish call from Stifel, which argued the marketing group's valuation overlooks a profit recovery driven by cost cuts and agency consolidation. The shares traded at 23.85p, up 4%, while the broker initiated coverage with a 'buy' rating and a 57p target, more than double the share price.

Stifel Deepens Fixed Income Platform with Senior Talent

globenewswire.com · 10 Sep 2026

Stifel Deepens Fixed Income Platform with Senior Talent

ST. LOUIS & LONDON, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the appointments of Conor Daly and Jim Franz as Co-Heads of Leveraged Finance Sales in Europe, further strengthening the firm's global Fixed Income platform.

Canada Pension Plan Investment Board Purchases Shares of 93,950 Stifel Financial Corporation $SF

defenseworld.net · 30 Aug 2026

Canada Pension Plan Investment Board Purchases Shares of 93,950 Stifel Financial Corporation $SF

Canada Pension Plan Investment Board purchased a new position in Stifel Financial Corporation (NYSE: SF) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 93,950 shares of the financial services provider's stock, valued at approximately $6,555,000. Canada Pension Plan Investment Board

Stifel Reports July 2026 Operating Data

globenewswire.com · 27 Aug 2026

Stifel Reports July 2026 Operating Data

ST. LOUIS, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for July 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.

Stifel reiterates Buy on Faron Pharmaceuticals after cash update secures runway to key trial readout

proactiveinvestors.co.uk · 26 Aug 2026

Stifel reiterates Buy on Faron Pharmaceuticals after cash update secures runway to key trial readout

Stifel has reiterated its 'buy' rating on Faron Pharmaceuticals Limited (AIM:FARN), the Finnish biotech, maintaining a price target of €2.50 after the company's interims, which showed the company well-funded to push on with value-accretive work in the clinic. The stock closed at €0.48 on 25 August, implying upside of 418.1% to the target price.

Bank of New York Mellon Corp Takes Position in Stifel Financial Corporation $SF

defenseworld.net · 25 Aug 2026

Bank of New York Mellon Corp Takes Position in Stifel Financial Corporation $SF

Bank of New York Mellon Corp acquired a new stake in Stifel Financial Corporation (NYSE: SF) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,336,318 shares of the financial services provider's stock, valued at approximately $93,235,000. Bank of New York Mellon Corp

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.